- Home
- ZUMZ vs TIL Comparison
ZUMZ vs TIL Comparison
Compare ZUMZ & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZUMZ
- TIL
- Stock Information
- Founded
- ZUMZ 1978
- TIL 2018
- Country
- ZUMZ United States
- TIL United States
- Employees
- ZUMZ N/A
- TIL N/A
- Industry
- ZUMZ Clothing/Shoe/Accessory Stores
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- ZUMZ Consumer Discretionary
- TIL Health Care
- Exchange
- ZUMZ Nasdaq
- TIL Nasdaq
- Market Cap
- ZUMZ 211.6M
- TIL 230.1M
- IPO Year
- ZUMZ 2005
- TIL 2021
- Fundamental
- Price
- ZUMZ $13.21
- TIL $23.87
- Analyst Decision
- ZUMZ Hold
- TIL Buy
- Analyst Count
- ZUMZ 1
- TIL 5
- Target Price
- ZUMZ $25.00
- TIL $119.00
- AVG Volume (30 Days)
- ZUMZ 264.1K
- TIL 310.5K
- Earning Date
- ZUMZ 09-04-2025
- TIL 08-12-2025
- Dividend Yield
- ZUMZ N/A
- TIL N/A
- EPS Growth
- ZUMZ N/A
- TIL N/A
- EPS
- ZUMZ 0.04
- TIL N/A
- Revenue
- ZUMZ $896,157,000.00
- TIL N/A
- Revenue This Year
- ZUMZ $3.31
- TIL N/A
- Revenue Next Year
- ZUMZ $1.34
- TIL N/A
- P/E Ratio
- ZUMZ $335.70
- TIL N/A
- Revenue Growth
- ZUMZ 3.01
- TIL N/A
- 52 Week Low
- ZUMZ $11.31
- TIL $9.85
- 52 Week High
- ZUMZ $31.37
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- ZUMZ 49.90
- TIL 46.54
- Support Level
- ZUMZ $12.91
- TIL $23.38
- Resistance Level
- ZUMZ $14.38
- TIL $26.91
- Average True Range (ATR)
- ZUMZ 0.60
- TIL 3.25
- MACD
- ZUMZ -0.06
- TIL -0.32
- Stochastic Oscillator
- ZUMZ 29.49
- TIL 31.75
About ZUMZ Zumiez Inc.
Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.